[1]
H. Tian and C. Wang, “Development Environment and SWOT Analysis of Biomedical SMEs after COVID-19: Evidence from China”, BCPBM, vol. 44, pp. 391–398, Apr. 2023, doi: 10.54691/bcpbm.v44i.4847.